FIELD: medicine, pharmacology. SUBSTANCE: it is suggested to use insulin sensitizers (thiazolidine diones, iminothiazolidinones, diiminothiazolidines, oxazolidine diones and oxa diazolidine diones) for treating and preventing hyperuricemia and pharmaceutical composition upon their basis of the same indication, as well. The innovation increases the number of medicinal preparations to treat and prevent podagra, hyperuricemic nephropathy, Lesch-Nyhan syndrome. EFFECT: higher efficiency of therapy and prophylaxis. 21 cl, 1 tbl
